Home/New York/Statutes/Law PBH: Public Health/Title 2: Prescription Drugs; Various Provisions/Art. 2-A: Prescription Drugs/§ 280-D
New York Statutes

§ 280-D — Patient notification of prescription label change

New York·Law PBH Public Health·Title 2 Prescription Drugs; Various Provisions·Art. 2-A Prescription Drugs
§ 280-d. Patient notification of prescription label change. A health\ncare prescriber shall inform the patient if such prescriber has included\nor has requested to include the name or address of the prescribing\nhealth care practice instead of the name of such prescriber on the\nprescription label when prescribing mifepristone or misoprostol.\n

Free access — add to your briefcase to read the full text and ask questions with AI

New York § 280-D (Patient notification of prescription label change) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Nearby Sections

15
§ 280
Medicaid drug cap
§ 280-A
Pharmacy benefit managers
§ 280-B
Unused prescription drug donation and redispensing program
§ 280-C
Pharmacy audits by pharmacy benefit managers
§ 280-D
Patient notification of prescription label change
§ 2800
Declaration of policy and statement of purpose
§ 2801
Definitions
§ 2801-A
Establishment or incorporation of hospitals
§ 2801-B
Improper practices in hospital staff appointments and extension of professional privileges prohibited
§ 2801-C
Injunctions
§ 2801-D
Private actions by patients of residential health care facilities
§ 2801-E
Voluntary residential health care facility rightsizing demonstration program
§ 2801-F
Residential health care facility quality incentive payment program
§ 2801-G
Community forum on hospital closure
§ 2801-H
Personal caregiving and compassionate caregiving visitors to nursing home residents during declared local or state health emergencies
View on official source ↗